Asia stocks gain after vaccine hopes push Wall Street to record highs

Reuters NEW YORK | Updated on November 17, 2020


HONG KONG/NEW YORK, Nov 17 (Reuters) - Asian stocks cautiously pushed further into record territory on Tuesday, and oil edged higher after U.S. benchmarks were pepped up by news of another promising coronavirus vaccine.

Investor sentiment was given a boost when Moderna Inc said its experimental COVID-19 vaccine was 94.5% effective in preventing infection based on interim late-state data.

The Cambridge, Massachusetts-based firm became the second drugmaker, after Pfizer Inc, to announce promising trial data in the development of a vaccine to defeat the pandemic. Its shares gained 9.6% on the day.

MSCI's broadest index of Asia-Pacific shares outside Japan gained 0.11% on Tuesday morning, a day after hitting its highest level since launching in 1987.

The MSCI World Index of global shares which also hit a record high on Monday, ticked higher still in Asia's morning trading.

“Investors are looking further ahead in the pandemic development into 2021, instead of focusing on the very challenging outbreak thats taking place in the U.S. and Europe now,” said Tai Hui, chief Asia market strategist, J.P. Morgan Asset Management, in emailed comments.

Hong Kong benchmark rose 0.1% and Australia's S&P/ASX 200 rose 0.23%, after Monday's trading had been severely curtailed by a software glitch

Japan's Nikkei 225 fell 0.2% after hitting a 29 year high the day before.

All three main Wall Street indexes advanced on Monday, led by cyclical and small cap names, with the Dow Jones Industrials Average setting a record as it neared the 30,000 mark for the first time in nine months.

“This is a continuation of what we saw last week as the vaccine being a catalyst for a rotation into cyclical sectors such as energy, financials, and defense with expectations for renewed demand and travel,” said Thomas Hayes, managing member at Great Hill Capital in New York.

Published on November 17, 2020

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor